Supernus Pharmaceuticals
SUPN
SUPN
265 hedge funds and large institutions have $2.07B invested in Supernus Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 101 increasing their positions, 94 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
265
Holders Change
+19
Holders Change %
+7.72%
% of All Funds
6.62%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.2%
New
44
Increased
101
Reduced
94
Closed
24
Calls
$13.2M
Puts
$9.15M
Net Calls
+$4.09M
Net Calls Change
+$3.05M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$42.4M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$32.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$24.8M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$21.5M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$17.6M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$24.3M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
-$17.5M |
| 3 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$15.9M |
| 4 |
FPC
Falcon Point Capital
San Francisco,
California
|
-$11M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$9.02M |
